Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on NDA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a novel metal-free synthesis for pyrimidoindazole compounds via patent CN109912606B. Offers cost reduction in API manufacturing and scalable production.
Patent CN104326892A details gold-catalyzed indanone synthesis offering high yield and green oxidation for reliable pharmaceutical intermediates supplier cost efficiency.
Patent CN102731386B reveals a novel Pd-catalyzed route for secondary diimides, offering neutral conditions and cost reduction in API manufacturing for global supply chains.
Patent CN112939780A details a Rh-catalyzed C-H activation route for indanones, offering high yields and functional group tolerance for reliable pharmaceutical intermediate supply chains.
Novel Rh-catalyzed oxidative coupling method for 2-methylene-1-indanone derivatives. Offers high purity, simplified workflow, and cost-effective API intermediate manufacturing solutions.
Novel metal-free synthesis of pyrimidoindazoles via one-pot cascade. High yields, mild conditions, ideal for API intermediates and kinase inhibitor development.
Advanced synthesis of chiral spiro bisphosphine ligands via Pd-catalyzed coupling. Delivers high-purity intermediates for asymmetric catalysis with scalable manufacturing.
Novel metal-free synthesis of pyrimidoindazoles via NH4I catalysis. High yields, mild conditions, ideal for API intermediates and kinase inhibitors.
Patent CN112675920B reveals a novel Ruthenium catalyst for efficient chiral alcohol synthesis. Discover cost reduction in pharmaceutical intermediate manufacturing and scalable production methods.
Patent CN114805209B details a metal-free photocatalytic route for 3-aryl-2H-indazoles, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN107641068A reveals a palladium-catalyzed route for indanone derivatives offering significant supply chain stability and reduced environmental waste for manufacturers.
Patent CN112939780A details a Rh-catalyzed C-H activation route for indanone derivatives, offering high yields and functional group tolerance for reliable pharmaceutical intermediate supply.
Patent CN103373963B reveals a safer route for pazopanib intermediates offering cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Patent CN110885315A details a high-yield synthesis of (R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one using early-stage resolution for superior purity and cost efficiency.
Patent CN108689892B discloses a novel CuI-catalyzed route for 3-sulfonylated indanones, offering mild conditions and high yields for cost-effective pharmaceutical intermediate manufacturing.
Patent CN108794420B discloses a novel bisoxazoline ligand synthesis from cheap bisphenols, offering significant cost reduction and scalable production for asymmetric catalysis.
Patent CN114805209A details a metal-free photocatalytic route for 3-aryl-2H-indazoles using aryl sulfonium salts, offering cost reduction and supply chain reliability.
Patent CN110028394B details a novel Pd-catalyzed carbonylation for indanones. This method offers cost reduction in API manufacturing and streamlined supply chains.
Patent CN112939780B details a robust Rh-catalyzed C-H activation route for indanone derivatives, offering high yields and simplified purification for API manufacturing.
Patent CN107628964B enables mild carbonylation for high-purity API intermediates. Reduces cost in fine chemical manufacturing with scalable Pd-catalyzed routes.